Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
Ahrén B, Simonsson E, Larsson H, Landin-Olsson M, Torgeirsson H, Jansson PA, Sandqvist M, Båvenholm P, Efendic S, Eriksson JW, Dickinson S, Holmes D.
Ahrén B, et al. Among authors: simonsson e.
Diabetes Care. 2002 May;25(5):869-75. doi: 10.2337/diacare.25.5.869.
Diabetes Care. 2002.
PMID: 11978683
Clinical Trial.